
Pilar Mur
@pilarmurm
Precision Oncology Program Coordinator at Catalan Health System @CatSalut Specialized in Cancer Research and Human Molecular Genetics. @AEGHgenetica @ciberonc
ID: 810707306744872960
19-12-2016 04:44:18
60 Tweet
87 Followers
229 Following



Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants mdpi.com/1211704 #mdpicancers Cancers MDPI IDIBELL @ICOnoticies @CIBERONC @CIBER_ESP TRANSCOLONCAN COST Action Asociación Española de Genética Humana (AEGH)


Un bon pas de Salut en la bona direcció d'implementar, cada cop més, la medicina genòmica al servei del pacient oncològic. Un plaer contribuir-hi des del servei de GeneticaSantPau de l' Sant Pau - Campus Salut Barcelona

🤔¿Qué es el cáncer? ¿El cáncer se puede heredar? 🧬¿Qué es un tumor raro de cólon o de mama si en realidad son cánceres muy comunes? 👩🔬La Dra Barbara Rivera te da respuestas en este video! 🍿📽️Estrenamos #Quinaciència 21 youtu.be/CpLJ8sbjpEI #LHciència #SinergiaLH #SC21CAT





In this 🧵you can read the results of our collaborative work on POLD1 just published as preprint. It has been amazing to work with such great minds. I’ve learnt so much! Vladimir Seplyarskiy Maria Andrianova Georgii Bazykin Fyodor Kondrashov, A. Kondrashov. IDIBELL @CIBERONC



Recommendations based on published evidence (data re-analysis) and thorough discussion of the results. By: Andy Latchford, @bhealdleach, Dr Ian Frayling 🇺🇦 #LongCovid, Pilar Mur, L. Katz, V. Moreno, G. Capellá & Laura Valle.

InSiGHT position statement on APC I1307K bit.ly/3LLAfjM ▶️ Should be tested in Ashkenazi Jewish individuals - Pathogenic, but low penetrance ▶️ Not enough evidence outside this population Laura Valle, Andy Latchford, Pilar Mur, Dr Ian Frayling 🇺🇦 #LongCovid, @bhealdleach




A new study allows a better interpretation of the results of genetic tests and make a better diagnosis and clinical follow-up of patients with #hereditarycancer, by Laura Valle and Pilar Mur in Genome Medicine ➡️ idibell.cat/en/2023/10/new…


Exploring co-occurring POLE exonuclease and non-exonuclease domain mutations and their impact on tumor mutagenicity. pubmed.ncbi.nlm.nih.gov/38207205/ By @SanjeevaniArora Michael J Hall. We are very grateful for this collaboration. Pilar Mur julenviana21 Laura Valle IDIBELL
